Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia

Clinical trial NCT01429610 · UNKNOWN

Trial details

NCT number: NCT01429610
Sponsor: Asan Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Start date: 2011-11-01
Primary completion: 2018-01-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.